Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Teunissen, C; Menge, T; Altintas, A; Álvarez-Cermeño, JC; Bertolotto, A; Berven, FS; Brundin, L; Comabella, M; Degn, M; Deisenhammer, F; Fazekas, F; Franciotta, D; Frederiksen, JL; Galimberti, D; Gnanapavan, S; Hegen, H; Hemmer, B; Hintzen, R; Hughes, S; Iacobaeus, E; Kroksveen, AC; Kuhle, J; Richert, J; Tumani, H; Villar, LM; Drulovic, J; Dujmovic, I; Khalil, M; Bartos, A.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Mult Scler. 2013; 19(13):1802-1809
Doi: 10.1177/1352458513488232
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fazekas Franz
- Khalil Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The choice of appropriate control group(s) is critical in cerebrospinal fluid (CSF) biomarker research in multiple sclerosis (MS). There is a lack of definitions and nomenclature of different control groups and a rationalized application of different control groups. We here propose consensus definitions and nomenclature for the following groups: healthy controls (HCs), spinal anesthesia subjects (SASs), inflammatory neurological disease controls (INDCs), peripheral inflammatory neurological disease controls (PINDCs), non-inflammatory neurological controls (NINDCs), symptomatic controls (SCs). Furthermore, we discuss the application of these control groups in specific study designs, such as for diagnostic biomarker studies, prognostic biomarker studies and therapeutic response studies. Application of these uniform definitions will lead to better comparability of biomarker studies and optimal use of available resources. This will lead to improved quality of CSF biomarker research in MS and related disorders.
- Find related publications in this database (using NLM MeSH Indexing)
- Biological Markers - cerebrospinal fluid
- Consensus -
- Control Groups -
- Humans -
- Multiple Sclerosis - cerebrospinal fluid Multiple Sclerosis - diagnosis
- Patient Selection -
- Research Design -
- Terminology as Topic -
- Find related publications in this database (Keywords)
- Biomarkers
- cerebrospinal fluid
- control groups
- study design